The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults

• Status: Completed
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

It is well known that magnesium sulfate has a membrane stabilizing effect , and broad spectrum anti arrhythmic properties. In this trial, the investigators study its prophylactic effect against atrial fibrillation in postoperative period of cardiac surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Magnesium Sulfate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Adult patients over 18 years.

• Left ventricular ejection fraction >0.3,

• Blood pressure is normal or less than 180/110.

• ASA ≤ III.

• Normal liver, pulmonary and renal function,

• No diabetes or other metabolism disorders,

• No pulmonary hypertension,

• No atrial fibrillation in the past, sinus rhythm on preoperative electrocardiogram.

Exclusion Criteria:

• history of AF,

• implanted pacemaker,

• postoperative myocardial infarction,

• use of left ventricular assist devices

• Renal failure or on hemodialysis